548 related articles for article (PubMed ID: 21079043)
1. Drug-induced long QT syndrome.
Kannankeril P; Roden DM; Darbar D
Pharmacol Rev; 2010 Dec; 62(4):760-81. PubMed ID: 21079043
[TBL] [Abstract][Full Text] [Related]
2. Cellular basis of drug-induced torsades de pointes.
Roden DM
Br J Pharmacol; 2008 Aug; 154(7):1502-7. PubMed ID: 18552874
[TBL] [Abstract][Full Text] [Related]
3. Predicting drug-induced QT prolongation and torsades de pointes.
Roden DM
J Physiol; 2016 May; 594(9):2459-68. PubMed ID: 26660066
[TBL] [Abstract][Full Text] [Related]
4. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.
Drici MD; Clément N
Drug Saf; 2001; 24(8):575-85. PubMed ID: 11480490
[TBL] [Abstract][Full Text] [Related]
5. Molecular predictors of drug-induced prolongation of the QT interval.
Dilaveris PE
Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):105-18. PubMed ID: 15853698
[TBL] [Abstract][Full Text] [Related]
6. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of drug induced QT interval prolongation.
Ponte ML; Keller GA; Di Girolamo G
Curr Drug Saf; 2010 Jan; 5(1):44-53. PubMed ID: 20210718
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
[TBL] [Abstract][Full Text] [Related]
9. [Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels].
Nakaya H
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):384-92. PubMed ID: 12835532
[TBL] [Abstract][Full Text] [Related]
10. Cardiac safety assays.
Heijman J; Voigt N; Carlsson LG; Dobrev D
Curr Opin Pharmacol; 2014 Apr; 15():16-21. PubMed ID: 24721649
[TBL] [Abstract][Full Text] [Related]
11. QT interval and drug therapy.
Drug Ther Bull; 2016 Mar; 54(3):33-6. PubMed ID: 26966121
[TBL] [Abstract][Full Text] [Related]
12. Double pharmacological challenge on repolarization opens new avenues for drug safety research.
Thomsen MB
Br J Pharmacol; 2007 Aug; 151(7):909-11. PubMed ID: 17549050
[TBL] [Abstract][Full Text] [Related]
13. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
Lawrence CL; Pollard CE; Hammond TG; Valentin JP
J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
[TBL] [Abstract][Full Text] [Related]
14. Predicting drug-induced QT prolongation and torsades de pointes: a review of preclinical endpoint measures.
Townsend C; Brown BS
Curr Protoc Pharmacol; 2013 Jun; Chapter 10():Unit 10.16. PubMed ID: 23744708
[TBL] [Abstract][Full Text] [Related]
15. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
16. The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.
Lopez-Medina AI; Chahal CAA; Luzum JA
Pharmacogenomics; 2022 Jun; 23(9):543-557. PubMed ID: 35698903
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
Shah RR
Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
[TBL] [Abstract][Full Text] [Related]
18. Acquired QT interval prolongation and HERG: implications for drug discovery and development.
Finlayson K; Witchel HJ; McCulloch J; Sharkey J
Eur J Pharmacol; 2004 Oct; 500(1-3):129-42. PubMed ID: 15464027
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced at interval prolongation: clinical, safety and regulatory updaes.
Di Girolamo G
Curr Drug Saf; 2010 Jan; 5(1):41-3. PubMed ID: 20218963
[No Abstract] [Full Text] [Related]
20. Dofetilide-induced long QT and torsades de pointes.
Aktas MK; Shah AH; Akiyama T
Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
